SSG
ATRC icon

Summit Securities Group’s AtriCure ATRC Stock Holding History

Summit Securities Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-208
Closed -$6K – 575
2024
Q1 		$6K Buy
+208
New +$6.97K ﹤0.01% 364

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Securities Group's ATRC Position: Q2 2024 in Review

Summit Securities Group sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 208 shares — an estimated $6K sold.

Summit Securities Group first reported a position in ATRC in Q1 2024 and held it in 1 quarter. The position peaked at $6K in Q1 2024. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Summit Securities Group reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Summit Securities Group sold 208 AtriCure shares in Q2 2024, an estimated $6K.
  • Summit Securities Group first reported a position in AtriCure in Q1 2024 and held it in 1 quarter.
  • Summit Securities Group's AtriCure position peaked at $6K in Q1 2024.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Summit Securities Group's 13F filing for Q2 2024, filed 26 Jul 2024.